Floyds - I hope you are right for the sakes of current...

Floyds - I hope you are right for the sakes of current shareholders - even though I have shorted this again. This may fall below cash backing, as the cash is possibly significantly tied up in a new clinical trial now.

The IP does not seem to be overly novel to me - Mannitol for inhalation doesn't seem to provide a building block for much IP to me. Why would anybody want to take it over? Why haven't they been accumulating enough to halt the SP slide if somebody is buying for that reason?

Seems to me there are bargain hunters buying this who then sell a bit lower when the buy doesn't seem to be working out. A vicious cycle possibly.